Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Creatinine
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Serum creatinine === Diagnostic serum creatinine studies are used to determine renal function.<ref name="Lewis_2016" /> The reference interval is 0.6β1.3 mg/dL (53β115 ΞΌmol/L).<ref name="Lewis_2016" /> It is simple to measure serum creatinine, and it is the most commonly used indicator of renal function.<ref name=ClinChem89>{{cite book| vauthors = Taylor EH |title=Clinical Chemistry|year=1989|publisher=Wiley |isbn=0-471-85342-9 |oclc=19065010 |pages=4, 58β62}}</ref> A rise in blood creatinine concentration is a late marker, observed only with marked damage to functioning [[nephron]]s. The test is therefore unsuitable for detecting early-stage [[kidney disease]]. A better estimate of kidney function is given by calculating the estimated glomerular filtration rate (eGFR). eGFR can be calculated without a 24-hour urine collection, using serum creatinine concentration and some or all of the following variables: sex, age, and weight, as suggested by the [[American Diabetes Association]].<ref>{{cite journal | vauthors = Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T | title = Diabetic nephropathy: diagnosis, prevention, and treatment | journal = Diabetes Care | volume = 28 | issue = 1 | pages = 164β76 | date = January 2005 | pmid = 15616252 | doi = 10.2337/diacare.28.1.164 | doi-access = free }}</ref> Many laboratories will automatically calculate eGFR when a creatinine test is requested. Algorithms to estimate GFR from creatinine concentration and other parameters are discussed in the [[Renal function#Estimated values|renal function]] article. Unfortunately, the MDRD Study equation was developed in people with chronic kidney disease, and its major limitations are imprecision and systematic underestimation of measured GFR (bias) at higher/normal values.<ref>{{cite journal | vauthors = Levey AS, Stevens LA, Schmid CH, Zhang YL, ((Castro AF 3rd)), Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J| title = A new equation to estimate glomerular filtration rate | journal = Ann Intern Med | date = 5 May 2009 | volume = 150 | issue = 9 | pages = 604β612 | pmid = 19414839 | pmc = 2763564 | doi = 10.7326/0003-4819-150-9-200905050-00006 | doi-access = free }}</ref> A concern as of late 2010 relates to the adoption of a new analytical method, and the possible effect this may have in clinical medicine. Most clinical laboratories now align their creatinine measurements against a new standardized [[isotope dilution mass spectrometry]] (IDMS) method to measure serum creatinine. IDMS appears to give lower values than older methods when the serum creatinine values are relatively low, for example 0.7 mg/dL. The IDMS method would result in comparative overestimation of the corresponding calculated GFR in some patients with normal renal function. A few medicines are dosed even in normal renal function using that derived value of GFR. The dose, unless further modified, could then be higher than desired, potentially causing increased drug-related toxicity. To counter the effect of changing to IDMS, new FDA guidelines have suggested limiting doses of carboplatin, a chemotherapy drug, to specified maxima.<ref>{{cite web|url=https://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm228974.htm|archive-url=https://web.archive.org/web/20111119090611/https://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm228974.htm|archive-date=2011-11-19|title=Carboplatin dosing|website=[[Food and Drug Administration]]|department=Center for Drug Evaluation and Research|url-status=dead}}</ref> A 2009 Japanese study found a lower serum creatinine concentration to be associated with an increased risk for the development of type 2 diabetes in Japanese men.<ref>{{cite journal | vauthors = Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, Endo G, Kambe H | title = Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study | journal = Diabetes Care | volume = 32 | issue = 3 | pages = 424β6 | date = March 2009 | pmid = 19074997 | pmc = 2646021 | doi = 10.2337/dc08-1265 }}</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Creatinine
(section)
Add topic